Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

Van Cutsem E.; Boni C.; Tabernero J.; Massuti B.; Middleton G.; Dane F.; Reichardt P.; Pimentel F. L.; Cohn A.; Follana P.; Clemens M.; Zaniboni A.; Moiseyenko V.; Harrison M.; Richards D. A.; Prenen H.; Pernot S.; Ecstein-Fraisse E.; Hitier S.; Rougier P.

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

【24h】

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

机译：多西他赛加奥沙利铂联合或不联合氟尿嘧啶或卡培他滨治疗转移性或局部复发性胃癌：一项II期随机研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Docetaxel/cisplatin/infusional 5-fluorouracil (5-FU; DCF) is a standard chemotherapy regimen for patients with advanced gastric cancer (GC). This phase II study evaluated docetaxel/oxaliplatin (TE), docetaxel/oxaliplatin/5-FU (TEF), and docetaxel/oxaliplatin/capecitabine (TEX) in patients with advanced GC.

机译：多西他赛/顺铂/输注5-氟尿嘧啶（5-FU; DCF）是晚期胃癌（GC）患者的标准化疗方案。这项II期研究评估了晚期GC患者中的多西他赛/奥沙利铂（TE），多西他赛/奥沙利铂/ 5-FU（TEF）和多西他赛/奥沙利铂/卡培他滨（TEX）。

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2015年第1期|共8页
作者
Van Cutsem E.; Boni C.; Tabernero J.; Massuti B.; Middleton G.; Dane F.; Reichardt P.; Pimentel F. L.; Cohn A.; Follana P.; Clemens M.; Zaniboni A.; Moiseyenko V.; Harrison M.; Richards D. A.; Prenen H.; Pernot S.; Ecstein-Fraisse E.; Hitier S.; Rougier P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
antineoplastic agents; combined; platinum compounds; stomach neoplasms; taxoids;

机译：抗肿瘤药;联合使用;铂化合物;胃肿瘤;类紫杉醇;

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study [J] . Van Cutsem E., Boni C., Tabernero J., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第1期

机译：多西他赛加奥沙利铂联合或不联合氟尿嘧啶或卡培他滨治疗转移性或局部复发性胃癌：一项II期随机研究
3. 51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325) [J] . E.Van Cutsem, V.Moiseyenko, S.Tjulandin, European Journal of Cancer Supplements . 2003,第5期

机译：51A多西他赛（D），顺铂（C）5-氟尿嘧啶（F）与顺铂（C）和5-氟尿嘧啶（F）在未接受化疗的转移性或局部复发性，不可切除的胃癌（MGC）患者中的比较：一项随机III期试验（V325）
4. Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study) [J] . Zaanan Aziz, Samalin Emmanuelle, Aparicio Thomas, Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver . 2018,第4期

机译：第III期随机试验比较5-氟尿嘧啶和奥沙利铂，在一线晚期胃癌化疗中有或没有多西紫杉醇（Gastfox研究）
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
7. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer [O] . Jinwan Wang, Ruihua Xu, Jian Li, -1

机译：改良多西紫杉醇和顺铂加氟尿嘧啶方案与顺铂和氟尿嘧啶作为晚期或局部复发性胃癌的一线治疗的多中心随机III期研究
8. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial [O] . Manlio Monti, Paolo Morgagni, Oriana Nanni, 2020

机译：术前或围手术期Docetaxel，Oxaliplatin和Capecitabine（Capecitabine（Gastrodoc植物）患者患者患有当地先进的可重置胃癌：随机期 - II试验

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

摘要

著录项

相似文献

相关主题

期刊订阅